KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Other Operating Expenses: 2010-2025

Historic Other Operating Expenses for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to $140,000.

  • Nektar Therapeutics' Other Operating Expenses fell 96.88% to $140,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.3 million, marking a year-over-year decrease of 166.93%. This contributed to the annual value of $6.0 million for FY2024, which is 96.19% down from last year.
  • According to the latest figures from Q3 2025, Nektar Therapeutics' Other Operating Expenses is $140,000, which was down 68.68% from $447,000 recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Other Operating Expenses registered a high of $103.2 million during Q1 2023, and its lowest value of -$31.1 million during Q4 2024.
  • Its 3-year average for Other Operating Expenses is $14.9 million, with a median of $8.2 million in 2023.
  • As far as peak fluctuations go, Nektar Therapeutics' Other Operating Expenses surged by 1,840.85% in 2023, and later crashed by 476.49% in 2024.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Other Operating Expenses stood at $6.2 million in 2021, then spiked by 144.33% to $15.1 million in 2022, then slumped by 45.23% to $8.2 million in 2023, then slumped by 476.49% to -$31.1 million in 2024, then plummeted by 96.88% to $140,000 in 2025.
  • Its Other Operating Expenses stands at $140,000 for Q3 2025, versus $447,000 for Q2 2025 and $169,000 for Q1 2025.